A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Clinical trial NCT04332822 · RECRUITING
Trial details
- NCT number
- NCT04332822
- Sponsor
- Nordic Lymphoma Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2025-12-28
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.